In honor of ALS Awareness Month, I AM ALS is rallying the nation on Thursday, May 22 for a Day of Action to shine a light on ...

Using the gene scissors CRISPR and stem cells, researchers at Stockholm University and the UK Dementia Research Institute (UK ...

Health and Human Services Secretary Robert F. Kennedy Jr. defended his proposed budget for next year on Tuesday amid ...

Peptidomimetics are synthetic analogs that retain the essential structure and function of peptides but with chemical ...

Zydus Lifesciences is targeting double-digit revenue growth for the fiscal year 2026, driven by robust performance in its ...

MaaT033, an experimental oral therapy that uses bacteria to restore balance in the gut, may slow ALS progression, a study ...

Understand how CT metrics match FVC in predicting ALS survival, offering a spirometry alternative for patients with bulbar ...

The US Food and Drug Administration (FDA) has granted clearance to BrainStorm Cell Therapeutics to commence a Phase IIIb ...

BrainStorm Cell Therapeutics saw rising retail chatter Monday when it obtained FDA clearance for Phase 3b clinical trials of ...